The psilocybin study funded by Orchard’s crowdfunding campaign should be ready to launch on 1 February 2021 despite the latest COVID lockdown in the UK.
Prof David Nutt, who leads the study, has confirmed that preparations for the study are continuing to make progress, with administrative approvals and the final approved clinical trial protocol expected to be ready by the start of 2021.
Orchard will be sending out more information once the study is ready to launch in order to let OCD patients know how they can apply to participate in the trial.
